🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Christoph Ganss

Rheacell (Germany)

ORCID: 0000-0003-0396-6591

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 11 papers. Top paper: “Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers”.

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Stem Cell Research & Therapy(2022)10.1186/s13287-022-03156-9

N/A

1.6DataRank · unranked

73 citations

Kathrin Dieter, Elke Niebergall‐Roth, Sabrina Klingele, Michael Jünger, Christoph Hasslacher +22 more

Clinical trial of ABCB5+ mesenchymal stem cells for recessive dystrophic epidermolysis bullosa

JCI Insight(2021)10.1172/jci.insight.151922

N/A

1.1DataRank · unranked

81 citations

Kathrin Dieter, Elke Niebergall‐Roth, Silvia Fluhr, Cristina Daniele, Jasmina Esterlechner +23 more

ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa

Cytotherapy(2023)10.1016/j.jcyt.2023.01.015

N/A

0.535DataRank · unranked

19 citations

Elke Niebergall‐Roth, Cristina Daniele, Silvia Fluhr, Natasha Y. Frank, Christoph Ganss +6 more

Translational development of ABCB5+ dermal mesenchymal stem cells for therapeutic induction of angiogenesis in non-healing diabetic foot ulcers

Research Square(2022)10.21203/rs.3.rs-1508134/v1

N/A

0.208DataRank · unranked

3 citations

Andreas Kerstan, Kathrin Dieter, Elke Niebergall‐Roth, Sabrina Klingele, Michael Jünger +22 more

Angiogenin Released from ABCB5+ Stromal Precursors Improves Healing of Diabetic Wounds by Promoting Angiogenesis

Journal of Investigative Dermatology(2021)10.1016/j.jid.2021.10.026

N/A

0DataRank · unranked

30 citations

Pallab Maity, Albert Koroma, Abhijit Basu, Rajeev Pandey, Seppe Vander Beken +17 more

ABCB5+ Dermal Mesenchymal Stromal Cells with Favorable Skin Homing and Local Immunomodulation for Recessive Dystrophic Epidermolysis Bullosa Treatment

Stem Cells(2021)10.1002/stem.3356

N/A

0DataRank · unranked

33 citations

Michael Pickett‐Leonard, Cindy Eide, Mark A. Kluth, Christoph Ganss, Natasha Y. Frank +3 more

Process development and safety evaluation of ABCB5+ limbal stem cells as advanced-therapy medicinal product to treat limbal stem cell deficiency

Stem Cell Research & Therapy(2021)10.1186/s13287-021-02272-2

N/A

0DataRank · unranked

37 citations

Jasmina Esterlechner, Elke Niebergall‐Roth, Ulf Dehio, Samar Sadeghi, Hannes M. Schröder +15 more

ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation

Cells(2023)10.3390/cells12131731

N/A

0DataRank · unranked

8 citations

Thomas Volatier, Karina Hadrian, Shuya Deng, Yanhong Hou, Mark A. Kluth +7 more

Kinetics of Wound Development and Healing Suggests a Skin-Stabilizing Effect of Allogeneic ABCB5+ Mesenchymal Stromal Cell Treatment in Recessive Dystrophic Epidermolysis Bullosa

Preprints.org(2023)10.20944/preprints202305.0357.v1

N/A

0DataRank · unranked

2 citations

Kathrin Dieter, Cristina Daniele, Silvia Fluhr, Maria Khokhrina, Inês Silva +4 more

Corrigendum to ABCB5+ mesenchymal stromal cells facilitate complete and durable wound closure in recessive dystrophic epidermolysis bullosa [Cytotherapy 25 (2023) 782–788/1562]

Cytotherapy(2023)10.1016/j.jcyt.2023.06.001

N/A

0DataRank · unranked

0 citations

Elke Niebergall‐Roth, Cristina Daniele, Silvia Fluhr, Natasha Y. Frank, Christoph Ganss +6 more

Potency assay to predict the anti-inflammatory capacity of a cell therapy product for macrophage-driven diseases: overcoming the challenges of assay development and validation

Cytotherapy(2024)10.1016/j.jcyt.2024.02.004

N/A

0DataRank · unranked

7 citations

Laura Nimtz, Elke Niebergall‐Roth, Alexandra Norrick, Stefan Hägele, Lena Vollmer +6 more